Phase Ib IIa clinical

Related by string. * phases . Phases . phase : Phase III clinical trials . Phase III trials . Phase 2b clinical / IBs . ib . IBS : irritable bowel syndrome IBS . Irritable Bowel Syndrome IBS . IBD TIPP / IIAS . IIA : Phase IIa clinical trials . IIa clinical trial . Phase IIa / clinicals . CLINICAL . Clinicals : placebo controlled clinical trials . Phase III clinical . Clinical Excellence NICE * *

Related by context. Frequent words. (Click for all words.) 65 Phase Ib clinical 64 phase IIa 62 multicenter clinical 61 phase IIb clinical 61 placebo controlled clinical 60 NSABP 60 Phase 1b clinical 60 clinical trial 60 phase IIb 59 prospective multicenter 58 Cloretazine R VNP#M 58 randomized controlled clinical 58 Phase 2a clinical 58 Phase III randomized 58 Phase 2b study 58 Phase IIa trial 58 randomized Phase III 58 pertuzumab 58 Phase 2a trial 57 Randomized controlled 57 prospective observational 57 Amrubicin 57 Phase III 57 Phase III pivotal 57 Phase 2b clinical 57 SWOG 57 Phase 2b trial 57 dalbavancin 57 Phase 1b trial 57 multicentre 57 phase 2a 57 placebo controlled Phase 56 double blinded placebo 56 Phase IIb clinical 56 Phase III clinical 56 dose escalation trial 56 registrational 56 nonrandomized 56 deforolimus 56 Phase Ia 56 KRN# 56 figitumumab 56 placebo controlled randomized 56 IIa trial 56 confirmatory Phase III 56 axitinib 56 RRMS patients 56 Cethrin 56 Urocidin 55 bevacizumab Avastin 55 clinical trials 55 multicenter 55 relapsing multiple sclerosis 55 Phase 1b 55 elotuzumab 55 Azedra 55 PEG SN# 55 rNAPc2 55 randomized clinical 55 Pivotal Phase III 55 abiraterone acetate 55 Multicenter 55 interferon beta 1b 55 Phase IIa 54 methylnaltrexone 54 Cethromycin 54 clinical 54 Phase II 54 Phase Ib 54 Phase IIa clinical 54 BAY #-# 54 MOZOBIL 54 bicifadine 54 prospective randomized controlled 54 multicenter study 54 IMC A# 54 subanalysis 54 GLPG# 54 Mipomersen 54 Targretin 54 IRESSA 54 tanespimycin 54 registrational trial 54 Advexin 54 subgroup analyzes 54 Phase IIb trial 54 ataluren 54 ZD# [001] 53 Phase IIb 53 Asentar 53 eniluracil 53 unblinding 53 mRCC 53 nitazoxanide 53 Phase 2a 53 ponatinib 53 metastatic hormone refractory 53 IND submission 53 nab paclitaxel 53 glatiramer acetate 53 pivotal Phase III

Back to home page